Medical Treatments for Prostate Cancer

There are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.

Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy.

The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped.

andy grove and prostate cancer
CRN
Grove's biggest project outside of Intel involves prostate cancer research. Moore puts it this way: "Andy is focused, organized, a superb manager.

Intel Executive Bio -- Andrew S. Grove
Dr. Grove is a Board member for the Prostate Cancer Foundation. At the University of California San Francisco (UCSF), he is Patient Advocate, and National

Prostate Cancer: No One Answer for Testing or Treatment No One
Improved screening tests and treatments for prostate cancer in very early Intel Corporation chairman Andy Grove, who was Time magazine's 1997 "Man of

5.13.96 TAKING ON PROSTATE CANCER
TAKING ON PROSTATE CANCER. ANDY GROVE REPORTER ASSOCIATE BETHANY MCLEAN. My secretary's face appeared in the conference room window.

Prostate Cancer Survivors - Treatment Choices
You may also find it useful to see how Andy Grove in went about his research in his article, "Taking on Prostate Cancer",

Andy Grove - Prostate Cancer Foundation
Andy Grove, Chief Executive Officer of Intel Inc. and a member of the Prostate Cancer Foundation, Board of Directors, shares his personal prostate cancer

USRF - Andy Grove: Taking on Prostate Cancer
Taking on Prostate Cancer. May 13, 1996. by Andy Grove with reporter associate Bethany McLean. The following account by Andy Grove, Chief Executive Officer

The Education of Andy Grove - December 12, 2005
Begin your lesson in leadership the same way Andy Grove attacks a problem: .. But when he was diagnosed with prostate cancer in 1995, Grove found himself

Prostate-Help: Taking On Prostate Cancer - The Andy Grove story
Taking On Prostate Cancer - The Andy Grove story. Link: Magazine - Taking On Prostate Cancer - Intro - FORTUNE. He came to the point immediately: 'Andy,

Article: Taking on Prostate Cancer by Andy Grove, Fortune Magazine
Fortune magazine article by Andy Grove about his fight with prostate cancer 5/13/96.

First-Person Stories about Sex, Relationships and Prostate Cancer
NOTABLE MEN. click here to go to story · CANCER DOESN'T READ RESUMyS Stories about Joe Torre, Andy Grove, Gen. Schwarzkopf, Harry Belafonte & more


andy grove and prostate cancer
download prostate video
brachytherapy prostate side effects
add link prostate treatment
green light laser for prostate